News | CPOD

In the September 2026 issue of The FASEB Journal, the Feldman Lab published "NONcNZO10/LtJ and TALLY-HO/JngJ Mice as Novel Models of Diabetic Peripheral Neuropathy."

In the August 2026 issue of JCI Insight, the Alumkal Lab published "Combined BET bromodomain and DNA methyltransferase inhibition targets critical survival pathways in transdifferentiated prostate cancer."

In the January 2026 issue of NPJ Regenerative Medicine, the Hankenson Lab published "Inhibition of CDK8 rescues impaired ischemic fracture healing."

CPOD Newsletter Fall 2026 Edition

In the February 2026 issue of Bone, the Liu Lab published "Loss of Tsc1 in Osterix-expressing cells leads to greater bone mass and strength in mice."

In the April 15 2026 issue of Nature Communications, the Rui Lab published "POMC neuron METTL14/m6A/YTHDC1/YTHDF2 pathways safeguard energy balance, body weight, and metabolism."